Test Price
3,000 AED✅ Home Collection Available
Colon Cancer Comprehensive Panel Genetic Test in UAE – 3000 AED
Executive Summary & Core Metrics
Comprehensive hereditary colon cancer risk assessment via next‑generation sequencing, delivered with 99.9% diagnostic sensitivity under ISO 9001:2015 accredited processing.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed physicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing test screens 33 genes associated with hereditary colorectal cancer syndromes such as Lynch syndrome and familial adenomatous polyposis, enabling early personalized prevention strategies.
Recommended by top UAE oncologists, gastroenterologists, and clinical geneticists, the panel delivers comprehensive risk stratification beyond single‑gene approaches.
Genes Analyzed: APC, ATM, AXIN2, BLM, BMPR1A, BRCA1, BRCA2, CDH1, CDKN2A, CHEK2, EPCAM, FLCN, GALNT12, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS2, POLD1, POLE, PRSS1, PTEN, RNF43, SMAD4, STK11, TGFBR2, TP53, VHL.
| Feature | Our Test (Colon Cancer Comprehensive Panel) | Alternative (Single Gene Sanger) |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing) | Sanger Sequencing |
| Genes Analyzed | 33 genes | 1–2 genes |
| Analytical Sensitivity | 99.9% | ~99% |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Price (AED) | 3,000 | Variable, often higher per gene |
Physician Insight & Safety Protocols
“This genomic panel offers critical insights into hereditary colon cancer predisposition; however, it is not a diagnostic test for active malignancy. A positive finding does not equate to a cancer diagnosis but signifies increased lifetime risk, necessitating close surveillance and consultation with your treating oncologist or gastroenterologist. I strongly recommend pre- and post‑test genetic counseling to fully understand the implications.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Important Advisory – Medication Notice
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing medical treatment.
Exclusion Criteria & Red Flags
- Not suitable if you have received a blood transfusion within the last 21 days (donor DNA interference).
- Not for minors (<18 years) without parental/legal guardian consent per UAE Federal Law No. 2 of 2019.
- Requires informed consent and a genetic counseling session (pedigree chart of affected relatives).
- If you experience acute symptoms such as rectal bleeding, sudden abdominal pain, or unexplained weight loss, seek emergency medical attention before genetic testing.
- Samples must be collected via our trained phlebotomists; self‑collection is not permitted.
Patient FAQ & Clinical Guidance
1. What genes does the Colon Cancer Comprehensive Panel test for?
Snippet: The test sequences 33 critical genes including APC, MLH1, MSH2, BRCA1/2, and TP53 to detect hereditary colon cancer risk.
2. How is the test performed and what sample is required?
Snippet: A blood sample, DNA extract, or dried blood spot on FTA card is collected through our VIP Mobile Phlebotomy & Cold-Chain Home Collection service.
3. What does a positive result mean for me?
Snippet: A positive result indicates a pathogenic variant that raises your lifetime colon cancer risk, prompting personalized surveillance and preventive strategies.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Protection:
- Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) ensuring your genomic and health data are encrypted and stored securely.
- Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for safe electronic health records management.
- All clinical testing and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Operated under DHA Facility License Number: 1143, DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | Colon Cancer Comprehensive Panel (33 genes) |
| Price (AED) | 3,000 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Z15.09, Z12.11 |
| LOINC Code | 81247-3 |
| DHA Facility License & Laboratory Address | License: 1143 | Lab: DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians